The single nucleotide polymorphism (SNP) **rs121918719** is located in the **FGFR3 (fibroblast growth factor receptor 3)** gene, which plays a critical role in bone development and maintenance. Variants in this gene, including rs121918719, are associated with specific clinical phenotypes, particularly skeletal dysplasias. This SNP is a pathogenic variant that results in the amino acid substitution **p.Gly380Arg (G380R)** in the FGFR3 protein. This gain-of-function mutation leads to constitutive activation of the FGFR3 receptor, disrupting normal bone growth.

The clinical phenotype most commonly associated with rs121918719 is **achondroplasia**, the most frequent form of dwarfism. Achondroplasia is characterized by disproportionate short stature, shortened limbs, macrocephaly, and characteristic facial features. The mutation affects endochondral ossification, leading to impaired growth of long bones and other skeletal abnormalities.

In summary, the location of rs121918719 in the FGFR3 gene directly influences the clinical phenotype by altering the function of the FGFR3 protein, resulting in the characteristic features of achondroplasia.

---

**日本語:**

一塩基多型（SNP）**rs121918719**は、骨の発達と維持に重要な役割を果たす**FGFR3（線維芽細胞増殖因子受容体3）**遺伝子に位置しています。この遺伝子の変異、特にrs121918719は、特定の臨床表現型、特に骨異形成症と関連しています。このSNPは病原性変異であり、FGFR3タンパク質のアミノ酸置換**p.Gly380Arg（G380R）**を引き起こします。この機能獲得型変異により、FGFR3受容体が恒常的に活性化され、正常な骨の成長が妨げられます。

rs121918719に最も一般的に関連する臨床表現型は、**軟骨無形成症（achondroplasia）**です。軟骨無形成症は、短肢型低身長、四肢の短縮、大頭症、特徴的な顔貌などを特徴とします。この変異は内軟骨性骨化に影響を与え、長骨や他の骨の成長障害を引き起こします。

まとめると、rs121918719のFGFR3遺伝子内での位置は、FGFR3タンパク質の機能を変化させることで臨床表現型に直接影響を与え、軟骨無形成症の特徴的な症状を引き起こします。